1.
Zhang X, Zhao Q, Tang H, Qin R, Tian T, Li C, et al. Laboratory Biomarkers and Immunological Modulation of Sintilimab in Gastric Cancer: A Meta-Analysis Focused on Tumor Markers and T-Cell Subsets: Sintilimab for Gastric Cancer: Efficacy, Markers, and Safety. J Med Biochem [Internet]. 2025 Jul. 10 [cited 2026 Jul. 12];44(6):1171-82. Available from: https://asistent.ceon.rs/index.php/jomb/article/view/59513